Company Overview and News

2
ASX hits six-month low as sell-off continues

2018-10-15 theage.com.au
The Australian sharemarket faced another investor sell-off on Monday as the major banks dipped the ASX 200 below 5,800 points for the first time since April.
IAUGY WANHY RIO BLT RIO BHPBF IAG SWM RTPPF IAUGF BHP RIO RTNTF BBL BHP BHPLF WANHF

2
ASX hits six-month low as sell-off continues

2018-10-15 watoday.com.au
The Australian sharemarket faced another investor sell-off on Monday as the major banks dipped the ASX 200 below 5,800 points for the first time since April.
IAUGY WANHY RIO BLT RIO BHPBF IAG SWM RTPPF IAUGF BHP RIO RTNTF BBL BHP BHPLF WANHF

2
ASX hits six-month low as sell-off continues

2018-10-15 smh.com.au
The Australian sharemarket faced another investor sell-off on Monday as the major banks dipped the ASX 200 below 5,800 points for the first time since April.
IAUGY WANHY RIO BLT RIO BHPBF IAG SWM RTPPF IAUGF BHP RIO RTNTF BBL BHP BHPLF WANHF

 
Youi says royal commission portrayed it in 'worst possible light'

2018-10-03 theage.com.au
Australia’s general insurers have hit back at preliminary findings from the royal commission, with Suncorp denying many allegations against it and Youi saying the commission sought to portray it in the “worst possible light”.
IAUGY IAUGF IAG

 
Youi says royal commission portrayed it in 'worst possible light'

2018-10-03 watoday.com.au
Australia’s general insurers have hit back at preliminary findings from the royal commission, with Suncorp denying many allegations against it and Youi saying the commission sought to portray it in the “worst possible light”.
IAUGY IAUGF IAG

 
Youi says royal commission portrayed it in 'worst possible light'

2018-10-03 smh.com.au
Australia’s general insurers have hit back at preliminary findings from the royal commission, with Suncorp denying many allegations against it and Youi saying the commission sought to portray it in the “worst possible light”.
IAUGY IAUGF IAG

 
ASX records worst performance in two weeks

2018-10-01 theage.com.au
Australian shares slumped to their worst performance in more than a fortnight on Monday as the banks lost gains they had made following the royal commission interim report's released on Friday.
IAUGY MQBKY IAUGF SNMYF SUN IAG SNMCY NYTAB MCQEF MQG

 
ASX records worst performance in two weeks

2018-10-01 watoday.com.au
Australian shares slumped to their worst performance in more than a fortnight on Monday as the banks lost gains they had made following the royal commission interim report's released on Friday.
IAUGY MQBKY IAUGF SNMYF SUN IAG SNMCY NYTAB MCQEF MQG

 
ASX records worst performance in two weeks

2018-10-01 smh.com.au
Australian shares slumped to their worst performance in more than a fortnight on Monday as the banks lost gains they had made following the royal commission interim report's released on Friday.
IAUGY MQBKY IAUGF SNMYF SUN IAG SNMCY NYTAB MCQEF MQG

2
Markets Live: ASX closes modestly higher

2018-09-26 watoday.com.au
Australian shares closed marginally higher on Wednesday, as the resource stocks continued to be weighed by the major financials ahead of the royal commission's interim report.
TMP WOPEF RIO BLT RIO SNMYF API SRHYY AGLNF IAG MDBPF OGFGY OISHF AGLNY RTPPF SUN SYR RTNTF ILKAY OSH IAUGY OISHY BHPBF ILKAF SNMCY WPL WHC ILU WOPEY SYAAF MDBKY MPL IAUGF BHP RIO BBL BHP OGFGF WAM BHPLF ORG

2
Financials weigh ASX ahead of Hayne interim report

2018-09-26 watoday.com.au
Australian shares closed marginally higher on Wednesday, as gains in resource stocks were partially offset by the major financials ahead of the royal commission's interim report.
WOPEF RIO BLT RIO SNMYF API AGLNF IAG MDBPF OGFGY OISHF AGLNY RTPPF SUN RTNTF OSH IAUGY OISHY BHPBF SNMCY WPL WHC WOPEY MDBKY MPL IAUGF BHP RIO BBL BHP OGFGF BHPLF ORG

2
Financials weigh ASX ahead of Hayne interim report

2018-09-26 theage.com.au
Australian shares closed marginally higher on Wednesday, as the resource stocks continued to be weighed by the major financials ahead of the royal commission's interim report.
WOPEF RIO BLT RIO SNMYF API AGLNF IAG MDBPF OGFGY OISHF AGLNY RTPPF SUN RTNTF OSH IAUGY OISHY BHPBF SNMCY WPL WHC WOPEY MDBKY MPL IAUGF BHP RIO BBL BHP OGFGF BHPLF ORG

2
Financials weigh ASX ahead of Hayne interim report

2018-09-26 smh.com.au
Australian shares closed marginally higher on Wednesday, as the resource stocks continued to be weighed by the major financials ahead of the royal commission's interim report.
WOPEF RIO BLT RIO SNMYF API AGLNF IAG MDBPF OGFGY OISHF AGLNY RTPPF SUN RTNTF OSH IAUGY OISHY BHPBF SNMCY WPL WHC WOPEY MDBKY MPL IAUGF BHP RIO BBL BHP OGFGF BHPLF ORG

 
CBD: Guthrie had 12 days of warning, did she notice?

2018-09-24 smh.com.au
Michelle Guthrie may be devastated by her sacking, but she can’t say it was a surprise.
IAUGY GJV PVH IAUGF NWS NWSA IAG EHE

 
IAG's Swann delayed reforms to protect market share

2018-09-19 theage.com.au
Insurance Australia Group offshoot Swann delayed reforming problematic sales practices, which had led to consumers buying dud cover, because it did not want to lose market share.
IAUGY IAUGF IAG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:IAG / INSURANCE AUSTRALIA GROUP LIMITED on message board site Silicon Investor.

Decision Diagnostics Corp (OTC: DECN) Decision Diagnostics Corp (OTC: DECN) Decision Diagnostics Corp (OTC: DECN) Russiagate! Russiagate! Russiagate!
IAMGOLD Corp IAMGOLD Corp IAMGOLD Corp Prostitution--the cement that binds marriage Prostitution--the cement that binds marriage Prostitution--the cement that binds marriage
NIA.V - Niagara Ventures Corp (Blu-Dot Beverages) NIA.V - Niagara Ventures Corp (Blu-Dot Beverages) NIA.V - Niagara Ventures Corp (Blu-Dot Beverages) Quest Diagnostics DGX Quest Diagnostics DGX Quest Diagnostics DGX
Gay Marriage Gay Marriage Gay Marriage QIAGEN (QGENF) - Star of Germanyu0027s Biotechs QIAGEN (QGENF) - Star of Germanyu0027s Biotechs QIAGEN (QGENF) - Star of Germanyu0027s Biotechs
QDEL - Quidel more quick diagnosis QDEL - Quidel more quick diagnosis QDEL - Quidel more quick diagnosis Hypertension Diagnostics Inc (HDII) Hypertension Diagnostics Inc (HDII) Hypertension Diagnostics Inc (HDII)